eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Licensing for novel vaccines against Mycobacterium tuberculosis (Mtb) H37Rv

eagle-i ID


Resource Type

  1. Access service


  1. Resource Description
    "A unique and modular bioinformatic process for the discovery of potential peptide vaccines against Mycobacterium tuberculosis (Mtb) has been developed by UH researchers. This process is based on the identification of diverse Human Leukocyte Antigens (HLA) involved in the response and protection to Mtb exposure and/or infection. The antigens are selected based on the host HLA genotype, making them designer vaccine peptides. The peptides can be combined in recombinant peptides or used as a cocktail of native proteins, in order to provide adequate global coverage. In addition to vaccine development, synthetic HLA peptides can be used for diagnostic purposes. By exploiting patients’ reactivity to their personal small synthetic HLA peptide and applying empirically determined thresholds, infection versus exposure can de determined via an in vitro Interferon-gamma (IFN-γ) release assay."
  2. Contact
    Park, Ann
  3. Service Provided by
    Office of Technology Transfer and Economic Development (OTTED)
  4. Website(s)
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016